Browse All

Current Filters

CLEAR FILTER x

TITLE

The First Light: Efficacy and Safety of a Multi-dose Study of Oveporexton (TAK-861), an Oral Orexin Receptor Two Agonist for the Treatment of Narcolepsy Type One

Elevated Influenza Antibodies in Recent Onset Type-one Narcolepsy

Author:Yan, Han   de Freitas Dias, Bruna   Lin, Ling   Zhang, Jing   Ricciardiello Mejia, Giorgio   Mignot, Emmanuel   

Session Name:P3: Sleep: Pathophysiology  

Topic:Headache  

Program Number:P3.012  

Author Institution:

Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study